Bojmar's lab
@bojmarlab.bsky.social
#CancerResearch at Linköping University and Weill Cornell
@liucancer.bsky.social
Led by Assistant Professor and Docent Linda Bojmar
Understanding organ crosstalk and its impact on cancer metastasis.
@liucancer.bsky.social
Led by Assistant Professor and Docent Linda Bojmar
Understanding organ crosstalk and its impact on cancer metastasis.
Pinned
Bojmar's lab
@bojmarlab.bsky.social
· Sep 5
In case you missed it...
Yesterday we announced the new 2025 ERC Starting Grant winners. 478 early-career researchers will be pushing the frontiers of science - from cancer and mental health to quantum breakthroughs.
👉 europa.eu/!89nG4M
5 explain what this funding means for their work & careers.👇
Yesterday we announced the new 2025 ERC Starting Grant winners. 478 early-career researchers will be pushing the frontiers of science - from cancer and mental health to quantum breakthroughs.
👉 europa.eu/!89nG4M
5 explain what this funding means for their work & careers.👇
Yesterday the @erc.europa.eu announced the 2025 Starting Grant winners. We’re beyond thrilled and grateful that our project SYST-E-MET: Systemic Effects on Metastasis – a look beyond the tumor was selected for funding!
🧫 🩺 Meet Chuanwen Fan
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
November 18, 2025 at 8:22 PM
🧫 🩺 Meet Chuanwen Fan
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
🧫 🩺 Meet Håkon Andersen Blomstrand
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
November 14, 2025 at 4:07 PM
🧫 🩺 Meet Håkon Andersen Blomstrand
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
🧬 Meet Carolin Jönsson
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
November 14, 2025 at 4:05 PM
🧬 Meet Carolin Jönsson
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
🩺 Meet Bergthor Björnsson
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
November 14, 2025 at 3:44 PM
🩺 Meet Bergthor Björnsson
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
🩺 Meet Per Sandström
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
November 14, 2025 at 2:11 PM
🩺 Meet Per Sandström
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
🧬 Meet Mohamed Elhusseiny
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
November 14, 2025 at 2:05 PM
🧬 Meet Mohamed Elhusseiny
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
🔬 Meet Alexander Sandberg
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
November 14, 2025 at 1:56 PM
🔬 Meet Alexander Sandberg
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
🩺 Meet Paulina Velasco Riestra
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
November 14, 2025 at 1:42 PM
🩺 Meet Paulina Velasco Riestra
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
🩺 Meet Constantinos Zambirinis
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
November 14, 2025 at 1:07 PM
🩺 Meet Constantinos Zambirinis
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
🩺 Meet Verena Unterkircher
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
November 14, 2025 at 1:05 PM
🩺 Meet Verena Unterkircher
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
🩺 Meet Erik Lundqvist
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
September 5, 2025 at 12:04 PM
🩺 Meet Erik Lundqvist
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
🩺️ Meet Karin Johansen
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
September 5, 2025 at 11:59 AM
🩺️ Meet Karin Johansen
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
🔬 Meet Jonas Burman
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
September 5, 2025 at 11:56 AM
🔬 Meet Jonas Burman
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
🩺 Meet Elena Arlaman
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
September 5, 2025 at 11:49 AM
🩺 Meet Elena Arlaman
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
🧪 Meet Linda Bojmar
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
September 5, 2025 at 11:43 AM
🧪 Meet Linda Bojmar
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
Reposted by Bojmar's lab
Cancer researcher Linda Bojmar at Linköping University has been awarded a Starting Grant from
@erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient.
#AcademicSky 🧪
liu.se/en/news-item/erc-starting-grant-till-linda-bojmar
@erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient.
#AcademicSky 🧪
liu.se/en/news-item/erc-starting-grant-till-linda-bojmar
ERC Starting Grant to Linda Bojmar
Linda Bojmar has been awarded just over SEK 16 million from the European Research Council, ERC. Her research aims to increase understanding of how pancreatic cancer spreads in the body and how treatme...
liu.se
September 4, 2025 at 11:57 AM
Cancer researcher Linda Bojmar at Linköping University has been awarded a Starting Grant from
@erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient.
#AcademicSky 🧪
liu.se/en/news-item/erc-starting-grant-till-linda-bojmar
@erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient.
#AcademicSky 🧪
liu.se/en/news-item/erc-starting-grant-till-linda-bojmar
Yesterday the @erc.europa.eu announced the 2025 Starting Grant winners. We’re beyond thrilled and grateful that our project SYST-E-MET: Systemic Effects on Metastasis – a look beyond the tumor was selected for funding!
In case you missed it...
Yesterday we announced the new 2025 ERC Starting Grant winners. 478 early-career researchers will be pushing the frontiers of science - from cancer and mental health to quantum breakthroughs.
👉 europa.eu/!89nG4M
5 explain what this funding means for their work & careers.👇
Yesterday we announced the new 2025 ERC Starting Grant winners. 478 early-career researchers will be pushing the frontiers of science - from cancer and mental health to quantum breakthroughs.
👉 europa.eu/!89nG4M
5 explain what this funding means for their work & careers.👇
September 5, 2025 at 11:19 AM
Yesterday the @erc.europa.eu announced the 2025 Starting Grant winners. We’re beyond thrilled and grateful that our project SYST-E-MET: Systemic Effects on Metastasis – a look beyond the tumor was selected for funding!
Reposted by Bojmar's lab
The 2025 ASCO meeting featured research on pancreatic cancer, including a new treatment modality and a novel treatment combination. bit.ly/43VHWOL #OncoSky
Pancreatic Cancer Research Highlights from ASCO Annual Meeting
The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.
bit.ly
June 23, 2025 at 3:04 PM
The 2025 ASCO meeting featured research on pancreatic cancer, including a new treatment modality and a novel treatment combination. bit.ly/43VHWOL #OncoSky
This work is the result of a great international collaboration!
Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch
molecular-cancer.biomedcentral.com/articles/10....
Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch
molecular-cancer.biomedcentral.com/articles/10....
Targeting metastasis in paediatric bone sarcomas - Molecular Cancer
Paediatric bone sarcomas (e.g. Ewing sarcoma, osteosarcoma) comprise significant biological and clinical heterogeneity. This extreme heterogeneity affects response to systemic therapy, facilitates inh...
molecular-cancer.biomedcentral.com
June 24, 2025 at 3:17 PM
This work is the result of a great international collaboration!
Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch
molecular-cancer.biomedcentral.com/articles/10....
Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch
molecular-cancer.biomedcentral.com/articles/10....
We are a part of the #FOSTER consortium (Fight OsteoSarcoma Through European Research). It proposes to connect multidisciplinary and patient/parent advocate expertise, at a Pan-European level to improve biological, translational and clinical research on #osteosarcoma to ultimately improve survival.
June 24, 2025 at 3:10 PM
We are a part of the #FOSTER consortium (Fight OsteoSarcoma Through European Research). It proposes to connect multidisciplinary and patient/parent advocate expertise, at a Pan-European level to improve biological, translational and clinical research on #osteosarcoma to ultimately improve survival.
This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:
June 24, 2025 at 1:02 PM
This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:
Reposted by Bojmar's lab
6/Timing of pancreas cancer metastasis. By profiling patient samples, the authors reveal immune remodeling in the pre-metastatic liver and propose liver sampling to determine pancreas cancer metastatic propensity.
David Lyden Weill Cornell
www.nature.com/articles/s41...
David Lyden Weill Cornell
www.nature.com/articles/s41...
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer - Nature Medicine
A multi-modal analysis of pre-metastatic liver biopsies from patients with localized pancreatic cancer with a minimum of 3 years of follow-up shows that immunological, proliferative and metabolomic fe...
www.nature.com
December 31, 2024 at 4:32 PM
6/Timing of pancreas cancer metastasis. By profiling patient samples, the authors reveal immune remodeling in the pre-metastatic liver and propose liver sampling to determine pancreas cancer metastatic propensity.
David Lyden Weill Cornell
www.nature.com/articles/s41...
David Lyden Weill Cornell
www.nature.com/articles/s41...
Curious about our research?🧬
Meet the Bojmar Lab and explore what drives our science!
Dive in here: liu.se/en/research/...
#CancerResearch #Metastasis #EVs #BojmarLab #TeamScience
Meet the Bojmar Lab and explore what drives our science!
Dive in here: liu.se/en/research/...
#CancerResearch #Metastasis #EVs #BojmarLab #TeamScience
Bojmar Lab
Cancer is a systemic disease. Our research focuses on understanding crosstalk between different organs in the human body, and how this affects cancer progression. We focus mainly on gastrointestinal c...
liu.se
June 18, 2025 at 12:00 PM
Curious about our research?🧬
Meet the Bojmar Lab and explore what drives our science!
Dive in here: liu.se/en/research/...
#CancerResearch #Metastasis #EVs #BojmarLab #TeamScience
Meet the Bojmar Lab and explore what drives our science!
Dive in here: liu.se/en/research/...
#CancerResearch #Metastasis #EVs #BojmarLab #TeamScience
Recently, we got to celebrate our postdoc Mohamed Elhusseiny. 2025 grant awardee from Dr Per Håkansson’s Foundation for Research!
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
June 18, 2025 at 11:55 AM
Recently, we got to celebrate our postdoc Mohamed Elhusseiny. 2025 grant awardee from Dr Per Håkansson’s Foundation for Research!
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
We want to thank Cancerfonden (the Swedish Cancer Society) for supporting cancer research at @liu.se
via.tt.se/pressmeddela...
via.tt.se/pressmeddela...
6 miljoner till cancerforskare vid LiU | Cancerfonden
Cancerfonden ger 6 miljoner kronor till cancerforskare vid Linköpings universitet. Forskningen vid LiU bidrar till framsteg inom tidig diagnostik och individanpassad behandling av cancer.
via.tt.se
June 18, 2025 at 11:28 AM
We want to thank Cancerfonden (the Swedish Cancer Society) for supporting cancer research at @liu.se
via.tt.se/pressmeddela...
via.tt.se/pressmeddela...